Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
1 Unit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2 Centre for Big Data Research in Health, University of New South Wales, Kensington Campus, New South Wales, Australia.
3 IVF Australia, Sydney, NSW, 2000, Australia.
4 Global Biostatistics, Merck KGaA, Darmstadt, Germany.
5 Department of Obstetrics and Gynecology, University of Monash, Monash, Clayton, Victoria, 3168, Australia. [email protected].
6 Alfred Health, Melbourne, VIC, 3004, Australia.
7 Global Clinical Development, Merck Serono S.p.A (an affiliate of Merck KGaA, Darmstadt 64293, Germany), Rome, 00176, Italy.
8 Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel.
9 The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, 6997801, Israel.
10 University of Modena and Reggio Emilia, Modena, MO, 41121, Italy.
11 GlobalMedical Affairs Fertility, Research and Development, Merck KGaA, F135/002, Darmstadt, 64293, Germany.
12 Flinders Fertility, Adelaide, South Australia, 5045, Australia.
13 College of Medicine and Public Health, Flinders University, Adelaide, South Australia, 5042, Australia.
14 Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, 3000, Belgium.
15 Department of Obstetrics and Gynecology, Yale University, New Haven, CT, 06510, USA.